Thrombin Generation in PRP of Normal and Glanzmann Thrombasthenia (GT) Patients
Patient . | Additions . | ETP % . | Peak Thrombin % . | PMPA % . |
---|---|---|---|---|
Normal | None | 100 | 100 | 100 |
Arab | ||||
A | None | 68 | 59 | 49 |
7E3 | 59 | 42 | 36 | |
7E3 + clots | 76 | 69 | 74 | |
B | None | 66 | 63 | 55 |
Clots | 78 | 77 | 102 | |
6F1 | 69 | 61 | 58 | |
6F1 + clots | 77 | 89 | 93 | |
C | None | 70 | 63 | 35 |
Clots | 101 | 89 | 52 | |
D | None | 35 | 26 | 44 |
Clots | 71 | 56 | 52 | |
7E3 | 25 | 16 | 28 | |
Iraqi-Jewish | ||||
A | None | 54 | 34 | 27 |
Clots | 69 | 55 | 41 | |
B | None | 71 | 63 | 48 |
7E3 | 70 | 58 | 45 | |
7E3 + clots | 87 | 91 | 61 | |
C | None | 63 | 45 | 36 |
7E3 | 65 | 41 | 42 | |
7E3 + clots | 77 | 67 | 44 | |
D | None | 65 | 47 | 57 |
Patient . | Additions . | ETP % . | Peak Thrombin % . | PMPA % . |
---|---|---|---|---|
Normal | None | 100 | 100 | 100 |
Arab | ||||
A | None | 68 | 59 | 49 |
7E3 | 59 | 42 | 36 | |
7E3 + clots | 76 | 69 | 74 | |
B | None | 66 | 63 | 55 |
Clots | 78 | 77 | 102 | |
6F1 | 69 | 61 | 58 | |
6F1 + clots | 77 | 89 | 93 | |
C | None | 70 | 63 | 35 |
Clots | 101 | 89 | 52 | |
D | None | 35 | 26 | 44 |
Clots | 71 | 56 | 52 | |
7E3 | 25 | 16 | 28 | |
Iraqi-Jewish | ||||
A | None | 54 | 34 | 27 |
Clots | 69 | 55 | 41 | |
B | None | 71 | 63 | 48 |
7E3 | 70 | 58 | 45 | |
7E3 + clots | 87 | 91 | 61 | |
C | None | 63 | 45 | 36 |
7E3 | 65 | 41 | 42 | |
7E3 + clots | 77 | 67 | 44 | |
D | None | 65 | 47 | 57 |
Values are expressed as a percentage of a normal control assayed concomitantly. Legend as in Table 1.